- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers in early-phase trials: fundamental issues
Authors
Keywords
-
Journal
Bioanalysis
Volume 10, Issue 12, Pages 933-944
Publisher
Future Science, LTD
Online
2018-06-20
DOI
10.4155/bio-2018-0006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Societal challenges of precision medicine: Bringing order to chaos
- (2017) Roberto Salgado et al. EUROPEAN JOURNAL OF CANCER
- Burdensome Research Procedures in Trials: Why Less Is More
- (2017) Jonathan Kimmelman et al. JNCI-Journal of the National Cancer Institute
- Burdensome Research Procedures in Trials: Why Less Is More
- (2017) Jonathan Kimmelman et al. JNCI-Journal of the National Cancer Institute
- STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
- (2015) Patrick M. Bossuyt et al. RADIOLOGY
- A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group
- (2014) Jacqueline Anne Hall et al. LANCET ONCOLOGY
- The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions
- (2014) Larry G Kessler et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Adjusting for misclassification in a stratified biomarker clinical trial
- (2014) Chunling Liu et al. STATISTICS IN MEDICINE
- Identifying a Subpopulation for a Tailored Therapy: Bridging Clinical Efficacy From a Laboratory-Developed Assay to a Validated In Vitro Diagnostic Test Kit
- (2014) Jonathan S. Denne et al. Statistics in Biopharmaceutical Research
- Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
- (2013) Lisa M McShane et al. BMC Medicine
- Analytical and clinical evaluation of biomarkers assays: When are biomarkers ready for prime time?
- (2013) Gene A Pennello Clinical Trials
- Criteria for the use of omics-based predictors in clinical trials
- (2013) Lisa M. McShane et al. NATURE
- Breaking a Vicious Cycle
- (2013) D. F. Hayes et al. Science Translational Medicine
- Biospecimen reporting for improved study quality (BRISQ)
- (2011) Helen M. Moore et al. CANCER CYTOPATHOLOGY
- Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs
- (2010) J Cummings et al. BRITISH JOURNAL OF CANCER
- Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
- (2010) J. E. Dancey et al. CLINICAL CANCER RESEARCH
- Effective Incorporation of Biomarkers into Phase II Trials
- (2009) L. M. McShane et al. CLINICAL CANCER RESEARCH
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Validation of Analytic Methods for Biomarkers Used in Drug Development
- (2008) C. H. Chau et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started